Tuesday, January 10, 2023 10:20:55 PM
Perhaps I don’t know enough but we are already know Pfizer etc have the proper distribution channels and production facilities in place.
Only two things are clear at this point. There’s still some doubt with the drug and until that’s addressed we won’t see consistent steady price appreciation. The other thing is MF probably won’t be successful going it alone with the fda according to many experts on this board since he isn’t big pharma.
We wait
Only two things are clear at this point. There’s still some doubt with the drug and until that’s addressed we won’t see consistent steady price appreciation. The other thing is MF probably won’t be successful going it alone with the fda according to many experts on this board since he isn’t big pharma.
We wait
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
